Projects funded by the NCN

The effects of ligands of the alpha7 nicotinic acetylcholine receptors on complex cognitive processes and social behavio...

Call: PRELUDIUM 8 , Panel: NZ7

Principal investigator: Agnieszka Potasiewicz

Instytut Farmakologii PAN

The effect of social stress during adolescence on the psychotic symptoms development and epigenetic mechanisms in the ne...

Call: OPUS 7 , Panel: NZ4

Principal investigator: dr hab. Marzena Maćkowiak

Instytut Farmakologii Polskiej Akademii Nauk

Antidepressats as substances that increase the activity of risperidone, an atypical antipsychotic drug in animal models

Call: PRELUDIUM 5 , Panel: NZ7

Principal investigator: Katarzyna Kamińska

Instytut Farmakologii PAN

The effects of positive allosteric modulators of alpha7 nicotinic acetylcholine receptors on complex cognitive processes...

Call: OPUS 4 , Panel: NZ7

Principal investigator: dr hab. Agnieszka Nikiforuk

Instytut Farmakologii PAN

The effect of enriched environment on the epigenetic mechanism in neurodevelopmental model of schizophrenia.

Call: PRELUDIUM 4 , Panel: NZ4

Principal investigator: dr Ewelina Bator

Instytut Farmakologii PAN

The evaluation of therapeutic potential of β-caryophyllene in animal schizophrenia model - behavioral and molecular stud...

Call: PRELUDIUM 21 , Panel: NZ7

Principal investigator: Magdalena Białoń

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Evaluation of the brain microbiome and proteome as well as the role of fecal microbiota transplantation (FMT) in schizop...

Call: SONATA 17 , Panel: NZ5

Principal investigator: dr Dominika Salamon

Uniwersytet Jagielloński, Collegium Medicum

Molecular profiling of novel antipsychotic drug candidates

Call: OPUS 20 , Panel: NZ7

Principal investigator: dr hab. Jan Rodriguez Parkitna

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Ocena roli wybranych białek neuronalnych i mikroglejowych w patogenezie schizofrenii - badania w modelu zwierzęcym.

Call: ETIUDA 7 , Panel: NZ4

Principal investigator: Katarzyna Chamera

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

The influence of muscarinic acetylcholine receptors (M1, M4 and M5) and serotonergic 5-HT1A receptor modulation on cogni...

Call: PRELUDIUM 16 , Panel: NZ7

Principal investigator: dr Paulina Cieślik

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

The role of epigenetic readers from BET family in the emergence and treatment of schizophrenia-like abnormalities in a n...

Call: OPUS 16 , Panel: NZ4

Principal investigator: prof. Marzena Maćkowiak

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Comparative effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ) and olanzapine on the cognitive dysfunction meas...

Call: OPUS 13 , Panel: NZ7

Principal investigator: dr hab. Agnieszka Wąsik

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

The neural circuitry underlying the generation of high frequency oscillations (HFO) in olfactory brain regions in a rat ...

Call: OPUS 12 , Panel: NZ4

Principal investigator: dr hab. Mark Hunt

Instytut Biologii Doświadczalnej im. M. Nenckiego Polskiej Akademii Nauk

Synthesis and pharmacological characterization of structurally diverse chemical analogues of compound PO-10 as multiple ...

Call: SONATA 11 , Panel: NZ7

Principal investigator: dr hab. Agnieszka Zagórska

Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

Prader-Willi Syndrome as a neurodevelopmental model of the immuno-inflammatory concept of psychotic disorders.

Call: PRELUDIUM 9 , Panel: NZ5

Principal investigator: Maja Krefft

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Lekarski